Session Information

Invited Symposium

[IS-FR-102] Emerging Therapies
Go back
print
Day
Apr 04 (Fri)
Time
08:30 - 10:00
Room
Room 6 - Tokyo International Forum 5F Hall D5
Topic
Pharmacology, Ocular Drug Delivery
Chair/Coordinator
Chair)Rajendra Apte、Chair)Itay Chowers、Chair)Taiji Sakamoto、Chair)Ashish Sharma
Description
We are in the middle of the golden age of new treatment for ocular diseases. Especially in retinal diseases, anti-VEGF drugs have changed the concept of treatment. But the change is still going on. In this symposium, the new and emerging therapies will be presented. Their targets are retinal degenerative diseases, which are unclimbed peaks so far. However, once the peak is climbed by some of them, we will be able to obtain another great prospect of treatment for various retinal diseases. You will see where we are and how close the peak is now.

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-1 / 

Pharmacology, Ocular Drug Delivery

Chemokine Receptors and Chemokines- Emerging Therapy for AMD

Itay Chowers

Chemokine Receptors and Chemokines- Emerging Therapy for AMD

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-2 / 

Pharmacology, Ocular Drug Delivery

Photoactive Quantum Dots for Neuroprotection in Progressive Retinal Degenerations

Jeffrey Olson

Photoactive Quantum Dots for Neuroprotection in Progressive Retinal Degenerations

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-3 / 

Pharmacology, Ocular Drug Delivery

Programmed Necrosis and Neuroprotection in Retinal Diseases

Demetrios Vavvas

Programmed Necrosis and Neuroprotection in Retinal Diseases

Duration 12min, Panel Discussion = Last 18min

IS-FR-102-4 / 

Pharmacology, Ocular Drug Delivery

APAO De Ocampo Lecture: Retinitis Pigmentosa: From Gene to Treatment- Possible Therapy by Optogenetics

Makoto Tamai

APAO De Ocampo Lecture: Retinitis Pigmentosa: From Gene to Treatment- Possible Therapy by Optogenetics

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-5 / 

Pharmacology, Ocular Drug Delivery

Clinical Trial of Gene Therapy for Retinitis Pigmentosa

Yasuhiro Ikeda

Clinical Trial of Gene Therapy for Retinitis Pigmentosa

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-6 / 

Pharmacology, Ocular Drug Delivery

iPS Cell-Derived Cell/Tissue Transplantation for Retinal Degenerative Diseases

Michiko Mandai

iPS Cell-Derived Cell/Tissue Transplantation for Retinal Degenerative Diseases

Duration 10min, Panel Discussion = Last 18min

IS-FR-102-7 / 

Pharmacology, Ocular Drug Delivery

Retinal Progenitor Cell Transplantation for Retinitis Pigmentosa

Henry Klassen

Retinal Progenitor Cell Transplantation for Retinitis Pigmentosa

Go back